As anticipated, High-OXPHOS MBMs expressed higher levels of PGC1α, a transcriptional co-factor that is a critical regulator of many OXPHOS-related genes in melanoma,9,11,23 compared to Low-OXPHOS MBMs (P.adj = .0188; Figure 2A). The gene discussed is PPARGC1A; the disease is melanoma.